SG Americas Securities’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623K | Sell |
19,707
-15,390
| -44% | -$487K | ﹤0.01% | 1361 |
|
|
2025
Q1 | $1.17M | Buy |
35,097
+12,599
| +56% | +$418K | ﹤0.01% | 948 |
|
|
2024
Q4 | $774K | Buy |
22,498
+6,774
| +43% | +$233K | ﹤0.01% | 867 |
|
|
2024
Q3 | $629K | Buy |
15,724
+11,158
| +244% | +$446K | ﹤0.01% | 1304 |
|
|
2024
Q2 | $138K | Buy |
+4,566
| New | +$138K | ﹤0.01% | 2083 |
|
|
2024
Q1 | – | Sell |
-8,945
| Closed | -$289K | – | 2760 |
|
|
2023
Q4 | $289K | Sell |
8,945
-11,408
| -56% | -$369K | ﹤0.01% | 1671 |
|
|
2023
Q3 | $667K | Buy |
+20,353
| New | +$667K | 0.01% | 1429 |
|
|
2023
Q1 | – | Sell |
-2,675
| Closed | -$147K | – | 3045 |
|
|
2022
Q4 | $147K | Buy |
+2,675
| New | +$147K | ﹤0.01% | 2215 |
|
|
2022
Q3 | – | Sell |
-17,626
| Closed | -$860K | – | 2932 |
|
|
2022
Q2 | $860K | Buy |
17,626
+6,761
| +62% | +$330K | 0.01% | 1284 |
|
|
2022
Q1 | $529K | Sell |
10,865
-7,166
| -40% | -$349K | ﹤0.01% | 1650 |
|
|
2021
Q4 | $769K | Buy |
18,031
+9,825
| +120% | +$419K | ﹤0.01% | 1666 |
|
|
2021
Q3 | $315K | Buy |
+8,206
| New | +$315K | ﹤0.01% | 2664 |
|